Fate Therapeutics, Inc. v. Shoreline Biosciences, Inc.

Good Law
United States District Court, Southern District of CaliforniaFebruary 1, 20233:22-cv-00676California1,107 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 10 FATE THERAPEUTICS, INC.; and Case No.: 22-cv-00676-H-MSB

WHITEHEAD INSTITUTE FOR

BIOMEDICAL RESEARCH, ORDER:

13 Plaintiffs, (1) GRANTING DEFENDANTS’ 14 v. MOTIONS TO FILE DOCUMENTS UNDER SEAL; SHORELINE BIOSCIENCES, INC.; and

DAN S. KAUFMAN, [Doc. Nos. 119, 122, 125, 138.] Defendants. (2) DIRECTING THE CLERK TO

FILE THE PROPOSED

DOCUMENTS UNDER SEAL ; AND

[Doc. Nos. 120, 123, 126, 139.]

22 (3) ORDERING DEFENDANT KAUFMAN TO PUBLICLY FILE

DOCKET ENTRY NO. 140

On January 27, 2023, Defendant Shoreline Biosciences, Inc. (“Shoreline”) filed a motion to partially dismiss Plaintiffs’ first amended complaint pursuant to Federal Rule of Civil Procedure 12(b)(6) for failure to state a claim. (Doc. No. 121.) On January 27, 2023, Shoreline also filed a motion to file under seal…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.